Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-21
DOI
10.3389/fmicb.2018.03158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bispecific antibody based therapeutics: Strengths and challenges
- (2018) Archana Thakur et al. BLOOD REVIEWS
- No Vacillation on HPV Vaccination
- (2018) Douglas Sipp et al. CELL
- Making anti-cytokine therapy more selective: Studies in mice
- (2018) Marina S. Drutskaya et al. CYTOKINE
- Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
- (2018) Jian Li et al. Journal of Hematology & Oncology
- Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
- (2018) Shivani Srivastava et al. JOURNAL OF IMMUNOLOGY
- Antiviral Activity of HIV gp120-Targeting Bispecific T Cell Engager Antibody Constructs
- (2018) Johannes Brozy et al. JOURNAL OF VIROLOGY
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
- (2018) Stephen J Bagley et al. NEURO-ONCOLOGY
- Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design
- (2018) Pamela A. Trail et al. PHARMACOLOGY & THERAPEUTICS
- Diphtheria vaccine: WHO position paper, August 2017 – Recommendations
- (2018) World Health Organization VACCINE
- Bispecific antibodies: design, therapy, perspectives
- (2018) Sergey Sedykh et al. Drug Design Development and Therapy
- Measuring trust in vaccination: A systematic review
- (2018) Heidi J. Larson et al. Human Vaccines & Immunotherapeutics
- Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30
- (2018) Louise E. Hogan et al. PLoS Pathogens
- Quarter Century of Anti-HIV CAR T Cells
- (2018) Thor A. Wagner Current HIV/AIDS Reports
- Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
- (2018) Markus Haug et al. Frontiers in Immunology
- Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy
- (2018) Jordan Gauthier et al. Current Research in Translational Medicine
- A homing system targets therapeutic T cells to brain cancer
- (2018) Heba Samaha et al. NATURE
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine
- (2017) Matt Wasserman et al. Expert Review of Vaccines
- The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
- (2017) Caroline Van Den Ende et al. Expert Review of Vaccines
- Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis
- (2017) Shashank Gupta et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
- (2017) Cynthia L. Gay et al. JOURNAL OF INFECTIOUS DISEASES
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis
- (2017) Qifang Bi et al. LANCET INFECTIOUS DISEASES
- Immunotherapeutic approaches to treatment of fungal diseases
- (2017) Darius Armstrong-James et al. LANCET INFECTIOUS DISEASES
- Strategies and challenges for the next generation of antibody–drug conjugates
- (2017) Alain Beck et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
- (2017) Xiulan Lai et al. PLoS One
- TIGIT: A Key Inhibitor of the Cancer Immunity Cycle
- (2017) Nicholas A. Manieri et al. TRENDS IN IMMUNOLOGY
- Antibody–Antibiotic Conjugates: A Novel Therapeutic Platform against Bacterial Infections
- (2017) Sanjeev Mariathasan et al. TRENDS IN MOLECULAR MEDICINE
- Targeted Immune Interventions for an HIV-1 Cure
- (2017) Matthieu Perreau et al. TRENDS IN MOLECULAR MEDICINE
- Measles vaccines: WHO position paper, April 2017 – Recommendations
- (2017) World Health Organization VACCINE
- Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma
- (2017) Xiezhao Li et al. Oncotarget
- Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS
- (2017) Anjie Zhen et al. PLoS Pathogens
- Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
- (2017) Dongfang Liu et al. Protein & Cell
- Bacterial Toxins for Cancer Therapy
- (2017) et al. Toxins
- A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
- (2017) Fu-Shun Hsu et al. Journal of Immunology Research
- Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients
- (2016) Amanda L. Gill et al. AIDS
- Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
- (2016) Ann Ager et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis
- (2016) Alimuddin Zumla et al. BMC Medicine
- Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model
- (2016) Manal Amoury et al. CANCER LETTERS
- An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
- (2016) Hasita Horlad et al. CANCER SCIENCE
- Management of toxicities of immune checkpoint inhibitors
- (2016) Lavinia Spain et al. CANCER TREATMENT REVIEWS
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
- (2016) Kole T. Roybal et al. CELL
- T-cell exhaustion in tuberculosis: pitfalls and prospects
- (2016) Nargis Khan et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
- (2016) KM Morrissey et al. CTS-Clinical and Translational Science
- Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection
- (2016) Eugene A Zhukovsky et al. CURRENT OPINION IN IMMUNOLOGY
- New concepts in HIV-1 vaccine development
- (2016) Kathryn E Stephenson et al. CURRENT OPINION IN IMMUNOLOGY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
- (2016) Christophe Massard et al. JOURNAL OF CLINICAL ONCOLOGY
- The future of antiviral immunotoxins
- (2016) Katja Spiess et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
- (2016) Alimuddin Zumla et al. LANCET INFECTIOUS DISEASES
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
- (2016) F Stephen Hodi et al. LANCET ONCOLOGY
- Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
- (2016) Jeffrey S Weber et al. LANCET ONCOLOGY
- Surface expression of inhibitory (CTLA-4) and stimulatory (OX40) receptors by CD4+ regulatory T cell subsets circulating in human malaria
- (2016) Raquel M. Gonçalves-Lopes et al. MICROBES AND INFECTION
- A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells
- (2016) N. Lilienthal et al. MOLECULAR CANCER THERAPEUTICS
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
- (2016) Grigory A. Efimov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections
- (2016) William E. Sause et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
- (2016) Glen M. Chew et al. PLoS Pathogens
- Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
- (2016) Vita Golubovskaya et al. Cancers
- Antibody Drug Conjugates: Application of Quantitative Pharmacology in Modality Design and Target Selection
- (2015) S. Sadekar et al. AAPS Journal
- Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
- (2015) Fiona Wightman et al. AIDS
- Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
- (2015) Eunhee G. Kim et al. Biomolecules & Therapeutics
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
- (2015) Haiming Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Manipulating IL-10 signalling blockade for better immunotherapy
- (2015) Guoying Ni et al. CELLULAR IMMUNOLOGY
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- New approaches to HIV vaccine development
- (2015) Barton F Haynes CURRENT OPINION IN IMMUNOLOGY
- Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis
- (2015) N. Li et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Dual-Affinity Re-Targeting proteins direct T cell–mediated cytolysis of latently HIV-infected cells
- (2015) Julia A.M. Sung et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab
- (2015) Thomas Köhnke et al. Journal of Hematology & Oncology
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- (2015) Sophie M. Lehar et al. NATURE
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolving Strategies for Target Selection for Antibody-Drug Conjugates
- (2015) Marc Damelin et al. PHARMACEUTICAL RESEARCH
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo
- (2015) Katja Spiess et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review
- (2015) Dilara Kiran et al. Seminars in Immunopathology
- Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
- (2015) J. U. Schmohl et al. Targeted Oncology
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- History of passive antibody administration for prevention and treatment of infectious diseases
- (2015) Barney S. Graham et al. Current Opinion in HIV and AIDS
- Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells
- (2015) Derek D. Sloan et al. PLoS Pathogens
- Broad-spectrum antiviral agents
- (2015) Jun-Da Zhu et al. Frontiers in Microbiology
- The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
- (2015) Katayoun Rezvani et al. Frontiers in Immunology
- Cytokine therapy restores antitumor responses of NK cells rendered anergic in MHC I-deficient tumors
- (2015) Michele Ardolino et al. OncoImmunology
- Lung-Residing Myeloid-derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis
- (2014) Julia K. Knaul et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antimalarial Activity of Granzyme B and Its Targeted Delivery by a Granzyme B–Single-Chain Fv Fusion Protein
- (2014) Stephanie Kapelski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Activity of a Single-Domain Antibody Immunotoxin Binding to Glycoprotein D of Herpes Simplex Virus 2
- (2014) Eileen M. Geoghegan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
- (2014) M. K. Gleason et al. BLOOD
- Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
- (2014) L. Karyampudi et al. CANCER RESEARCH
- Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B
- (2014) Pengfei Yuan et al. CELL RESEARCH
- FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
- (2014) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Phage antibody display libraries: a powerful antibody discovery platform for immunotherapy
- (2014) Aizhi Zhao et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Vaccine immunity against fungal infections
- (2014) Som G. Nanjappa et al. CURRENT OPINION IN IMMUNOLOGY
- Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia
- (2014) Y.-A. Que et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Molecular and Transcriptional Basis of CD4+ T Cell Dysfunction during Chronic Infection
- (2014) Alison Crawford et al. IMMUNITY
- Mechanisms of Neutralization of a Human Anti-α-toxin Antibody
- (2014) Vaheh Oganesyan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
- (2014) Sophie Steeland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Limitations of Foxp3+ Treg depletion following viral infection in DEREG mice
- (2014) Allison F. Christiaansen et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Bactericidal Action of a Complement-Independent Antibody against Relapsing Fever Borrelia Resides in Its Variable Region
- (2014) Timothy J. LaRocca et al. JOURNAL OF IMMUNOLOGY
- Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection
- (2014) V. Cecchinato et al. JOURNAL OF IMMUNOLOGY
- Early or Late IL-10 Blockade Enhances Th1 and Th17 Effector Responses and Promotes Fungal Clearance in Mice with Cryptococcal Lung Infection
- (2014) Benjamin J. Murdock et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
- (2014) P. R. Kumaresan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- More Surprises in the Development of an HIV Vaccine
- (2014) José Esparza et al. Frontiers in Immunology
- Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia
- (2013) L. Hua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
- (2013) D Hristodorov et al. BRITISH JOURNAL OF CANCER
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Designing Tomorrow's Vaccines
- (2013) Gary J. Nabel NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity
- (2013) Fabian Richter et al. PLoS One
- Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
- (2013) M. J. Fuller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tolerance and exhaustion: defining mechanisms of T cell dysfunction
- (2013) Andrea Schietinger et al. TRENDS IN IMMUNOLOGY
- Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection
- (2013) Nasiema Allie et al. Scientific Reports
- Macrophage and T Cell Produced IL-10 Promotes Viral Chronicity
- (2013) Kirsten Richter et al. PLoS Pathogens
- Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
- (2013) Bryan Berube et al. Toxins
- TGF-β signalling and its role in cancer progression and metastasis
- (2012) Yvette Drabsch et al. CANCER AND METASTASIS REVIEWS
- Antibody-Based Immunotherapy of Cancer
- (2012) Louis M. Weiner et al. CELL
- scFv Antibody: Principles and Clinical Application
- (2012) Zuhaida Asra Ahmad et al. Clinical & Developmental Immunology
- Blockade of IL-10 Signaling during Bacillus Calmette-Guerin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN- and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection
- (2012) J. M. Pitt et al. JOURNAL OF IMMUNOLOGY
- Chronic Exposure to Plasmodium falciparum Is Associated with Phenotypic Evidence of B and T Cell Exhaustion
- (2012) J. Illingworth et al. JOURNAL OF IMMUNOLOGY
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Therapeutic Blockade of Transforming Growth Factor Beta Fails To Promote Clearance of a Persistent Viral Infection
- (2012) L. Garidou et al. JOURNAL OF VIROLOGY
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein
- (2012) Deboeeta Chatterjee et al. mAbs
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models
- (2012) Flavia De Bernardis et al. VACCINE
- NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
- (2012) Clint S. Schmidt et al. VACCINE
- TGF-β Blockade Does Not Improve Control of an Established Persistent Viral Infection
- (2012) Tobias Boettler et al. VIRAL IMMUNOLOGY
- Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
- (2012) Thomas Gardner et al. Human Vaccines & Immunotherapeutics
- An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection
- (2011) Yingyun Cai et al. ANTIVIRAL RESEARCH
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
- (2011) Barry J Allen Immunotherapy
- Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
- (2011) Ming Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells
- (2011) A. A. Kruglov et al. JOURNAL OF IMMUNOLOGY
- Clinical radioimmunotherapy—the role of radiobiology
- (2011) Jean-Pierre Pouget et al. Nature Reviews Clinical Oncology
- Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points
- (2011) K. K. Dietze et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Therapeutic Enhancement of Protective Immunity during Experimental Leishmaniasis
- (2011) Senad Divanovic et al. PLoS Neglected Tropical Diseases
- Tregs in infection and vaccinology: heroes or traitors?
- (2011) Luciana Berod et al. Microbial Biotechnology
- Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11
- (2010) M. P. Horn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transforming growth factor-β and the hallmarks of cancer
- (2010) Maozhen Tian et al. CELLULAR SIGNALLING
- New Insights of CTLA-4 into Its Biological Function in Breast Cancer
- (2010) H. Mao et al. CURRENT CANCER DRUG TARGETS
- Features of responding T cells in cancer and chronic infection
- (2010) Peter S Kim et al. CURRENT OPINION IN IMMUNOLOGY
- Catumaxomab
- (2010) Rolf Linke et al. mAbs
- Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
- (2010) Elias A Said et al. NATURE MEDICINE
- Treatment of respiratory syncytial virus with palivizumab: a systematic review
- (2010) Jia Hu et al. World Journal of Pediatrics
- Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs
- (2010) Edward A. Berger et al. PLoS Pathogens
- Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
- (2009) Mrudula Mathew et al. CANCER SCIENCE
- The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses
- (2009) Alison Crawford et al. CURRENT OPINION IN IMMUNOLOGY
- Editorial [Hot Topic: Recombinant Immunotoxins – The Next Generation (Executive Editor: Stefan Barth)]
- (2009) Stefan Barth CURRENT PHARMACEUTICAL DESIGN
- Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer
- (2009) K Birkholz et al. GENE THERAPY
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dual Control of Antitumor CD8 T Cells through the Programmed Death-1/Programmed Death-Ligand 1 Pathway and Immunosuppressive CD4 T Cells: Regulation and Counterregulation
- (2009) A. J. Currie et al. JOURNAL OF IMMUNOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
- (2008) M. Baer et al. INFECTION AND IMMUNITY
- Many cytokines are very useful therapeutic targets in disease
- (2008) Marc Feldmann JOURNAL OF CLINICAL INVESTIGATION
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Signalling, inflammation and arthritis: NF- B and its relevance to arthritis and inflammation
- (2008) R. E. Simmonds et al. RHEUMATOLOGY
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now